Perioral angioedema associated with angiotensin-converting enzyme inhibitor

Mark E. Peacock, Dong S. Park, Gary D. Swiec, Kenneth J. Erley

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Background: Angioedema is a non-pruritic swelling usually limited to the skin and mucous membranes of the face and perioral soft tissues. It can be life threatening but usually is not, and can be managed with conservative medical treatment unless the airway is endangered. Recent reports suggest that angiotensin-converting enzyme (ACE) inhibitors can predispose and/or precipitate angioedema, with a predilection toward patients of African American ancestry. Methods: This case report involved a 65-year-old African American female who was being treated surgically for localized chronic periodontitis. The procedure was performed without incident, and the patient was alert and stable when released. The next day, the patient called and reported that her lips were swollen. She stated that this had happened a number of times over the past several years, sometimes related to eating shellfish and other times without any known precipitating factor. All previous episodes of perioral swelling occurred after ACE inhibitor therapy had been initiated. Results: The patient was in no distress, with no other site involvement. She was prescribed oral hydroxyzine and her appearance returned to normal after 5 days. Although the patient had experienced previous episodes of angioedema, none had been in response to any dental procedure. She was referred to the Allergy and Immunology Clinic for skin testing, the results of which were negative to shellfish with good controls. Other potentiating etiologies were also ruled out by the allergist. Conclusions: Angioedema is a recognized possible side effect of ACE inhibitor therapy. The exact mechanism by which ACE inhibitors induce angioedema is not known, although the risk of occurrence is much greater in African Americans. Practitioners should be alert to this potentially fatal condition in patients who take ACE inhibitors or the newer angiotensin II receptor blockers.

Original languageEnglish (US)
Pages (from-to)651-654
Number of pages4
JournalJournal of Periodontology
Volume76
Issue number4
DOIs
StatePublished - Apr 1 2005
Externally publishedYes

Fingerprint

Angioedema
Angiotensin-Converting Enzyme Inhibitors
African Americans
Enzyme Therapy
Shellfish
Hydroxyzine
Precipitating Factors
Chronic Periodontitis
Skin
Angiotensin Receptor Antagonists
Lip
Allergy and Immunology
Tooth
Mucous Membrane
Eating

Keywords

  • Angioneurotic edema/etiology
  • Angiotensin receptor blocker
  • Angiotensin-converting enzyme inhibitors
  • Blacks

ASJC Scopus subject areas

  • Dentistry(all)

Cite this

Perioral angioedema associated with angiotensin-converting enzyme inhibitor. / Peacock, Mark E.; Park, Dong S.; Swiec, Gary D.; Erley, Kenneth J.

In: Journal of Periodontology, Vol. 76, No. 4, 01.04.2005, p. 651-654.

Research output: Contribution to journalArticle

Peacock, Mark E. ; Park, Dong S. ; Swiec, Gary D. ; Erley, Kenneth J. / Perioral angioedema associated with angiotensin-converting enzyme inhibitor. In: Journal of Periodontology. 2005 ; Vol. 76, No. 4. pp. 651-654.
@article{c12bc32ca16741969a21d0c835c4d8b6,
title = "Perioral angioedema associated with angiotensin-converting enzyme inhibitor",
abstract = "Background: Angioedema is a non-pruritic swelling usually limited to the skin and mucous membranes of the face and perioral soft tissues. It can be life threatening but usually is not, and can be managed with conservative medical treatment unless the airway is endangered. Recent reports suggest that angiotensin-converting enzyme (ACE) inhibitors can predispose and/or precipitate angioedema, with a predilection toward patients of African American ancestry. Methods: This case report involved a 65-year-old African American female who was being treated surgically for localized chronic periodontitis. The procedure was performed without incident, and the patient was alert and stable when released. The next day, the patient called and reported that her lips were swollen. She stated that this had happened a number of times over the past several years, sometimes related to eating shellfish and other times without any known precipitating factor. All previous episodes of perioral swelling occurred after ACE inhibitor therapy had been initiated. Results: The patient was in no distress, with no other site involvement. She was prescribed oral hydroxyzine and her appearance returned to normal after 5 days. Although the patient had experienced previous episodes of angioedema, none had been in response to any dental procedure. She was referred to the Allergy and Immunology Clinic for skin testing, the results of which were negative to shellfish with good controls. Other potentiating etiologies were also ruled out by the allergist. Conclusions: Angioedema is a recognized possible side effect of ACE inhibitor therapy. The exact mechanism by which ACE inhibitors induce angioedema is not known, although the risk of occurrence is much greater in African Americans. Practitioners should be alert to this potentially fatal condition in patients who take ACE inhibitors or the newer angiotensin II receptor blockers.",
keywords = "Angioneurotic edema/etiology, Angiotensin receptor blocker, Angiotensin-converting enzyme inhibitors, Blacks",
author = "Peacock, {Mark E.} and Park, {Dong S.} and Swiec, {Gary D.} and Erley, {Kenneth J.}",
year = "2005",
month = "4",
day = "1",
doi = "10.1902/jop.2005.76.4.651",
language = "English (US)",
volume = "76",
pages = "651--654",
journal = "Journal of Periodontology",
issn = "0022-3492",
publisher = "American Academy of Periodontology",
number = "4",

}

TY - JOUR

T1 - Perioral angioedema associated with angiotensin-converting enzyme inhibitor

AU - Peacock, Mark E.

AU - Park, Dong S.

AU - Swiec, Gary D.

AU - Erley, Kenneth J.

PY - 2005/4/1

Y1 - 2005/4/1

N2 - Background: Angioedema is a non-pruritic swelling usually limited to the skin and mucous membranes of the face and perioral soft tissues. It can be life threatening but usually is not, and can be managed with conservative medical treatment unless the airway is endangered. Recent reports suggest that angiotensin-converting enzyme (ACE) inhibitors can predispose and/or precipitate angioedema, with a predilection toward patients of African American ancestry. Methods: This case report involved a 65-year-old African American female who was being treated surgically for localized chronic periodontitis. The procedure was performed without incident, and the patient was alert and stable when released. The next day, the patient called and reported that her lips were swollen. She stated that this had happened a number of times over the past several years, sometimes related to eating shellfish and other times without any known precipitating factor. All previous episodes of perioral swelling occurred after ACE inhibitor therapy had been initiated. Results: The patient was in no distress, with no other site involvement. She was prescribed oral hydroxyzine and her appearance returned to normal after 5 days. Although the patient had experienced previous episodes of angioedema, none had been in response to any dental procedure. She was referred to the Allergy and Immunology Clinic for skin testing, the results of which were negative to shellfish with good controls. Other potentiating etiologies were also ruled out by the allergist. Conclusions: Angioedema is a recognized possible side effect of ACE inhibitor therapy. The exact mechanism by which ACE inhibitors induce angioedema is not known, although the risk of occurrence is much greater in African Americans. Practitioners should be alert to this potentially fatal condition in patients who take ACE inhibitors or the newer angiotensin II receptor blockers.

AB - Background: Angioedema is a non-pruritic swelling usually limited to the skin and mucous membranes of the face and perioral soft tissues. It can be life threatening but usually is not, and can be managed with conservative medical treatment unless the airway is endangered. Recent reports suggest that angiotensin-converting enzyme (ACE) inhibitors can predispose and/or precipitate angioedema, with a predilection toward patients of African American ancestry. Methods: This case report involved a 65-year-old African American female who was being treated surgically for localized chronic periodontitis. The procedure was performed without incident, and the patient was alert and stable when released. The next day, the patient called and reported that her lips were swollen. She stated that this had happened a number of times over the past several years, sometimes related to eating shellfish and other times without any known precipitating factor. All previous episodes of perioral swelling occurred after ACE inhibitor therapy had been initiated. Results: The patient was in no distress, with no other site involvement. She was prescribed oral hydroxyzine and her appearance returned to normal after 5 days. Although the patient had experienced previous episodes of angioedema, none had been in response to any dental procedure. She was referred to the Allergy and Immunology Clinic for skin testing, the results of which were negative to shellfish with good controls. Other potentiating etiologies were also ruled out by the allergist. Conclusions: Angioedema is a recognized possible side effect of ACE inhibitor therapy. The exact mechanism by which ACE inhibitors induce angioedema is not known, although the risk of occurrence is much greater in African Americans. Practitioners should be alert to this potentially fatal condition in patients who take ACE inhibitors or the newer angiotensin II receptor blockers.

KW - Angioneurotic edema/etiology

KW - Angiotensin receptor blocker

KW - Angiotensin-converting enzyme inhibitors

KW - Blacks

UR - http://www.scopus.com/inward/record.url?scp=19044393871&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=19044393871&partnerID=8YFLogxK

U2 - 10.1902/jop.2005.76.4.651

DO - 10.1902/jop.2005.76.4.651

M3 - Article

C2 - 15857108

AN - SCOPUS:19044393871

VL - 76

SP - 651

EP - 654

JO - Journal of Periodontology

JF - Journal of Periodontology

SN - 0022-3492

IS - 4

ER -